Medical Devices News and Research

RSS

IBA's PBS system for Proton Therapy granted CE Mark

IBA's second generation Pencil Beam Scanning system for Proton Therapy, which further enhances the performance of anti-cancer proton treatments, has been granted the CE Mark, certifying that the product has met European Union medical device regulations.

16 Apr 2010

OrbusNeich Medical awarded US patent for "Stent with Helical Elements"

OrbusNeich Medical, Inc., a designer, developer, manufacturer and marketer of innovative medical devices for the treatment of cardiovascular diseases, today announced that on March 23, 2010, the Company was granted U.S. Patent No. 7,682,384 B2, entitled "Stent with Helical Elements." The patent relates to an expandable stent comprised of a plurality of helical segments. The Company noted that it has identified unlicensed use by Boston Scientific Corporation of certain technologies protected under U.S. Patent No. 7,682,384 B2.

15 Apr 2010

Phase II clinical study examining CTT's Calmare pain therapy medical device completed

Competitive Technologies, Inc. announced today that Thomas J. Smith, MD FACP, and co-investigator Patrick J. Coyne, MSN, APRN, FAAN, of Virginia Commonwealth University's Massey Cancer Center have completed their open Phase II clinical study examining CTT's Calmare pain therapy medical device's efficacy treating patients suffering with severe pain from chemotherapy induced peripheral neuropathy.

15 Apr 2010

First patient enrolled in Endologix percutaneous EVAR pivotal clinical trial

Endologix, Inc., developer of minimally invasive treatments for aortic disorders, announced today that the first patient has been enrolled in the Company's prospective, multicenter, randomized clinical trial for a bilateral percutaneous approach to endovascular abdominal aortic aneurysm repair.

15 Apr 2010

Articulinx closes $10M Series B financing round

Articulinx, Inc., a medical device company developing a novel minimally-invasive approach for the treatment of osteoarthritis, announced today the closing of a $10M Series B financing led by US Venture Partners (USVP).

15 Apr 2010

Drug company payments to doctors: Continuing controversy

The New York Times has two stories on pharmaceutical industry payments to physicians and experts.

15 Apr 2010

Noncompetitive ''win-win'' relationship between gynecologist and radiologist benefits patients

Journal of Minimally Invasive Gynecology (JMIG) has published a study in its March/April issue which concluded that establishing a referral relationship with an interventional radiologist for comprehensive uterine myoma (fibroid) treatment supports a trusting, collaborative, long-term, noncompetitive ''win-win'' relationship between the gynecologist and radiologist.

13 Apr 2010

Study supports use of Fisher Wallace Cranial Stimulator for treating depression, anxiety and insomnia

Fisher Wallace Laboratories today announced the results of a brain stimulation study involving the Fisher Wallace Cranial Stimulator, a portable medical device that treats depression, anxiety and insomnia. The study, published in The Neuroscientist and authored by Dr. Felipe Fregni, assistant professor in neurology at Harvard Medical School, analyzes a decade's worth of research on the brain stimulation technology used by the Fisher Wallace Cranial Stimulator.

13 Apr 2010

Biomedical Systems selects Global 360's Process360 BPM suite for improving report, image communication

Global 360, a leading provider of Process and Document Management solutions, today announced that Biomedical Systems, a global leader in centralized diagnostic testing for the pharmaceutical and medical device industry, has chosen Global 360 to improve how critical reports and images are communicated and reported to its customers. In the process, the company will also save thousands on courier costs, satisfy a "going green" initiative, and mitigate risk, helping satisfy auditors and regulators.

12 Apr 2010

Competitive Technologies to introduce Calmare pain therapy at medical conference

Competitive Technologies, Inc. announced today that it will hold a conference for the medical community on May 17, 2010, in Boston, Mass. at the Marriott Long Wharf Hotel from 9:00 a.m. to 3:30 p.m., to introduce CTT's Calmare® pain therapy to the medical community. Professor Giuseppe Marineo, MD, DSc., Researcher, Founding President of Delta Research and Development, Tor Vergata University of Rome, is the Italian inventor of the "Scrambler Therapy," the technology used in the Calmare medical device.

12 Apr 2010

Alphatec Holdings proposes 8 million common stock public offering

Alphatec Holdings, Inc., the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus on treating conditions related to the aging spine, announced that it is offering to sell 8,000,000 primary shares of its common stock and a selling shareholder, HealthpointCapital Partners, L.P., is offering 8,000,000 shares of Alphatec common stock in an underwritten public offering.

12 Apr 2010

Alphatec Spine's first-quarter preliminary consolidated revenues up 25.6%

Alphatec Holdings, Inc., the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus on treating conditions related to the aging spine, announces today that, based on preliminary financial data, the Company will report record consolidated quarterly revenues of approximately $38.4 million for the first quarter 2010, an increase of 25.6% from the $30.6 million reported for the first quarter 2009.

12 Apr 2010

Pfizer discloses payments to doctors

In Pennsylvania, the payments suggested that "[p]harmaceutical company money continued flowing to University of Pittsburgh Medical Center doctors last year, despite a restrictive two-year-old policy designed to limit drug company influence, and reflecting the struggle academic medical centers face in distancing doctors from drug companies," the Pittsburgh Business Times reports

12 Apr 2010

Medtronic named 2010 MDEA winner for excellence in medical device design

Medtronic announced today that the company was named a 2010 Medical Device Excellence Award winner for excellence in medical device design for its Hydrodebrider System, manufactured by the company's Ear Nose and Throat business unit.

9 Apr 2010

One-third of the ICD market up for grabs

A survey of physicians by Majestic Research found that Boston Scientific's March 15 decision to withdraw from the ICD market will have a meaningful long-term impact. Among surveyed electrophysiologists, 56% report the recent announcements and actions have negatively impacted their perceptions of the overall quality of Boston Scientific's ICD devices and 52% said that they would be less likely to use the company's devices in the future.

9 Apr 2010

Philips to sell Sectra PACS in Japan

Sectra and Philips have completed an agreement whereby Philips will sell Sectra PACS in Japan under a joint branding policy. The agreement revitalizes a partnership that ended in 2005, by which Sectra and Philips combined were among the market leaders for PACS.

9 Apr 2010

Investment report on CardioNet from StockPreacher.com

StockPreacher.com announces an investment report featuring CardioNet, Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.

8 Apr 2010

Xhale Innovations wins 2010 Medical Design Excellence Award for HyGreen hand hygiene system

HyGreen™, developed by Xhale Innovations, Inc., has been selected as a winner in the 2010 Medical Design Excellence Awards competition, one of the most prestigious awards in the medical device industry. The announcement comes on the heels of winning the 2009 Popular Science Best of What's New Award, and is the latest success for this market-defining product.

8 Apr 2010

Angiotech Pharmaceuticals acquires manufacturing, intellectual property rights from Haemacure

Angiotech Pharmaceuticals, Inc., a specialty pharmaceutical and medical device company, today announced the closing of its acquisition of certain product candidates and technology assets of Haemacure Corporation. Haemacure has been involved in proceedings under Canada's Bankruptcy and Insolvency Act and Chapter 11 of the United States Bankruptcy Code.

8 Apr 2010

University of Minnesota-Twin Cities recognizes Rich Nazarian with 2010 DMD Conference Award

Rich Nazarian, Minnetronix, Inc. President and CEO, will be recognized for his dedication to the medical device community by the University of Minnesota-Twin Cities with the honor of the 2010 Design of Medical Devices Conference Award.

8 Apr 2010

Medical Devices News and Research

IBA's PBS system for Proton Therapy granted CE Mark

OrbusNeich Medical awarded US patent for "Stent with Helical Elements"

Phase II clinical study examining CTT's Calmare pain therapy medical device completed

First patient enrolled in Endologix percutaneous EVAR pivotal clinical trial

Articulinx closes $10M Series B financing round

Drug company payments to doctors: Continuing controversy

Noncompetitive ''win-win'' relationship between gynecologist and radiologist benefits patients

Study supports use of Fisher Wallace Cranial Stimulator for treating depression, anxiety and insomnia

Biomedical Systems selects Global 360's Process360 BPM suite for improving report, image communication

Competitive Technologies to introduce Calmare pain therapy at medical conference

Alphatec Holdings proposes 8 million common stock public offering

Alphatec Spine's first-quarter preliminary consolidated revenues up 25.6%

Pfizer discloses payments to doctors

Medtronic named 2010 MDEA winner for excellence in medical device design

One-third of the ICD market up for grabs

Philips to sell Sectra PACS in Japan

Investment report on CardioNet from StockPreacher.com

Xhale Innovations wins 2010 Medical Design Excellence Award for HyGreen hand hygiene system

Angiotech Pharmaceuticals acquires manufacturing, intellectual property rights from Haemacure

University of Minnesota-Twin Cities recognizes Rich Nazarian with 2010 DMD Conference Award

Industry Focus eBook - Medical Devices (3rd Edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News